Literature DB >> 30572743

Surgical management of pelvic organ prolapse.

C F Maher1, K K Baessler2, M D Barber3, C Cheong4, E C J Consten5, K G Cooper6, X Deffieux7, V Dietz8, R E Gutman9, J J van Iersel10, C W Nager11, V W Sung12, R de Tayrac13.   

Abstract

Despite pelvic organ prolapse being a universal problem experienced in nearly 50% of parous women, the surgical management of vaginal prolapse remains an enigma to many, with wide variation in the rates and types of intervention performed. As part of the 6th International Consultation on Incontinence (ICI) our committee, charged with producing an evidence-based report on the surgical management of prolapse, produced a pathway for the surgical management of prolapse. The 2017 ICI surgical management of prolapse evidence-based pathway will be presented and summarized. Weaknesses of the data and pathway will be discussed and avenues for future research proposed.

Entities:  

Keywords:  Pelvic organ prolapse; pathway; surgery

Mesh:

Year:  2018        PMID: 30572743     DOI: 10.1080/13697137.2018.1551348

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  3 in total

1.  Evaluation of Different 'Tensioning' of Apical Suspension in Women Undergoing Surgery for Prolapse and Urinary Incontinence.

Authors:  Sebastian Ludwig; Samira Göktepe; Peter Mallmann; Wolfram Jäger
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  MicroRNA-124-3p affects myogenic differentiation of adipose-derived stem cells by targeting Caveolin-1 during pelvic floor dysfunction in Sprague Dawley rats.

Authors:  Hao Chen; Zihao Li; Ming Lin; Xuling Lv; Jingping Wang; Qing Wei; Zikai Zhang; Liqun Li
Journal:  Ann Transl Med       Date:  2021-01

3.  Comparison of first versus second line sacrocolpopexies in terms of morbidity and mid-term efficacy.

Authors:  Marine Lallemant; A T M Grob; M Puyraveau; M A G Perik; A H H Alhafidh; M Cosson; R Ramanah
Journal:  Sci Rep       Date:  2022-09-29       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.